24 HR Pramipexole dihydrochloride 2.25 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Pramipexole Dihydrochloride Extended-Release Tablets are indicated for the treatment of Parkinson's disease. Pramipexole dihydrochloride extended-release tablets are a non-ergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD) ( 1 )

Par Pharmaceutical, Inc.

FDA Reported Adverse Reactions
`[1] pain` `[2] drug ineffective` `[3] drug hypersensitivity` `[4] drug dependence` `[5] toxicity to various agents` `[6] overdose` `[7] nausea` `[8] fatigue` `[9] off label use` `[10] completed suicide`

3 years ago

OVAL WHITE 305

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Pramipexole Dihydrochloride Extended-Release Tablets are available as follows: 0.375 mg : white to off-white round film-coated tablets engraved with “251” on one side and plain on the other side. Bottles of 30….NDC 10370-251-11 0.75 mg : white to off-white round film-coated tablets engraved with “252” on one side and plain on the other side. Bottles of 30….NDC 10370-252-11 1.5 mg : white to off-white oval film-coated tablets engraved with “253” on one side and plain on the other side. Bottles of 30….NDC 10370-253-11 2.25 mg : white to off-white oval film-coated tablets engraved with “305” on one side and plain on the other side Bottles of 30….NDC 10370-305-11 3 mg : white to off-white oval film-coated tablets engraved with “254” on one side and plain on the other side. Bottles of 30….NDC 10370-254-11 3.75 mg : white to off-white oval film-coated tablets engraved with “306” on one side and plain on the other side. Bottles of 30….NDC 10370-306-11 4.5 mg : white to off-white oval film-coated tablets engraved with “255” on one side and plain on the other side. Bottles of 30….NDC 10370-255-11 16.2 Storage and Handling Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. Protect from exposure to high humidity. Store in a safe place out of the reach of children.

More pills like OVAL 305

Related Pills

24 HR Pramipexole dihydrochloride 3.75 MG Extended Release Oral Tablet

Par Pharmaceutical, Inc.

24 HR Pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet

Par Pharmaceutical, Inc.

24 HR Pramipexole dihydrochloride 3 MG Extended Release Oral Tablet

Par Pharmaceutical, Inc.

24 HR Pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet

Par Pharmaceutical, Inc.

24 HR Pramipexole dihydrochloride 0.75 MG Extended Release Oral Tablet

par pharmaceutical, inc.

pramipexole dihydrochloride extendedrelease pramipexole tablet extended release

Par Pharmaceutical, Inc.

dextroamphetamine sulfate capsule extended release

actavis pharma, inc.

Dextroamphetamine Sulfate 15 MG Extended Release Oral Capsule

Actavis Pharma, Inc.

Dextroamphetamine Sulfate 15 MG Extended Release Oral Capsule

Actavis Pharma, Inc.

Dextroamphetamine Sulfate 15 MG Extended Release Oral Capsule

Actavis Pharma, Inc.

24 HR Amphetamine aspartate 2.5 MG Amphetamine Sulfate 2.5 MG Dextroamphetamine saccharate 2.5 MG Dextroamphetamine Sulfate 2.5 MG Extended Release Oral Capsule

Actavis Pharma, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site